Single-dose and steady-state pharmacokinetics of a novel microfluidized suspension of atovaquone in human immunodeficiency virus-seropositive patients.
about
Phase I safety and pharmacokinetics study of micronized atovaquone in human immunodeficiency virus-infected infants and children. Pediatric AIDS Clinical Trials Group.Antiparasitic agent atovaquoneAntimalarial pharmacology and therapeutics of atovaquoneEfavirenz but Not Atazanavir/Ritonavir Significantly Reduces Atovaquone Concentrations in HIV-Infected SubjectsThe anti-malarial atovaquone increases radiosensitivity by alleviating tumour hypoxia.
P2860
Single-dose and steady-state pharmacokinetics of a novel microfluidized suspension of atovaquone in human immunodeficiency virus-seropositive patients.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Single-dose and steady-state p ...... y virus-seropositive patients.
@en
Single-dose and steady-state p ...... y virus-seropositive patients.
@nl
type
label
Single-dose and steady-state p ...... y virus-seropositive patients.
@en
Single-dose and steady-state p ...... y virus-seropositive patients.
@nl
prefLabel
Single-dose and steady-state p ...... y virus-seropositive patients.
@en
Single-dose and steady-state p ...... y virus-seropositive patients.
@nl
P2093
P2860
P1476
Single-dose and steady-state p ...... y virus-seropositive patients.
@en
P2093
P2860
P304
P407
P577
1996-03-01T00:00:00Z